Novartis AG - Company Profile

All the sales intelligence you need on Novartis AG in one solution.

Save hours of research time with a comprehensive
Sales Intelligence Solution.
Understand how Novartis AG fits into your total
addressable market and Ideal Customer Profile.
Gain competitive edge with triggers that tell you
when and how to engage with Novartis AG.

Novartis AG: Premium Databases

Contact the team or request a demo to find out how our data can drive your business forward

Remove risk and uncertainty, gain a competitive edge and secure actionable leads with access to company-related investigative journalist content.

Headline	Published	Journalists
Showing 3 of 900+ results.
Deserunt mollit sunt Lorem laborum do id aliqua dolore	16 Dec 2022	Lorem
LoA Update: Novartis’s Oncology Assets See Lowered Advancement Prospects After Phase I/II Termination	13 Dec 2022	Urte Fultinaviciute
CMO Moves: Regulatory Catalysts for Drug Manufacturing – December	12 Dec 2022	Manasi Vaidya
Humira Biosimilars Set the Stage for Long-Awaited 2023 US Launches	06 Dec 2022	Adam Zamecnik

Delivers exclusive investigative journalist content including breaking news and analysis ahead of market-moving events.

Drug Insights:

Forward-looking, nuanced, qualitative asset analysis on development, approval & market/reimbursement potential
Material intelligence on competitors, including breaking news
Insight on companies’ business development needs and strategies

Outsourcing Insights:

Insight on companies’ CRO and business development needs, strategies and relationships

Remove risk and uncertainty

Gain a competitive edge

Secure actionable leads

Gain a 360-degree view of Novartis AG and make more informed decisions for your business

Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer